These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 15956085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G, Neuer K, Ranke MB, Wittekindt NE.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [Abstract] [Full Text] [Related]

  • 3. Noonan syndrome: relationships between genotype, growth, and growth factors.
    Limal JM, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S, Vidaud M, Le Bouc Y.
    J Clin Endocrinol Metab; 2006 Jan; 91(1):300-6. PubMed ID: 16263833
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.
    Noordam C, Peer PG, Francois I, De Schepper J, van den Burgt I, Otten BJ.
    Eur J Endocrinol; 2008 Sep; 159(3):203-8. PubMed ID: 18562489
    [Abstract] [Full Text] [Related]

  • 6. Excellent growth response to growth hormone therapy in a child with PTPN11-negative Noonan syndrome and features of growth hormone resistance.
    Walton-Betancourth S, Martinelli CE, Thalange NK, Dyke MP, Acerini CL, White S, Camacho-Hübner C, Savage MO.
    J Endocrinol Invest; 2007 May; 30(5):439-41. PubMed ID: 17598979
    [Abstract] [Full Text] [Related]

  • 7. Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation.
    Choi JH, Lee BH, Jung CW, Kim YM, Jin HY, Kim JM, Kim GH, Hwang JS, Yang SW, Lee J, Yoo HW.
    Horm Res Paediatr; 2012 May; 77(6):388-93. PubMed ID: 22777296
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome.
    Yoshida R, Hasegawa T, Hasegawa Y, Nagai T, Kinoshita E, Tanaka Y, Kanegane H, Ohyama K, Onishi T, Hanew K, Okuyama T, Horikawa R, Tanaka T, Ogata T.
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3359-64. PubMed ID: 15240615
    [Abstract] [Full Text] [Related]

  • 10. [Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation].
    Ferreira LV, Souza SA, Montenegro LR, Arnhold IJ, Pasqualini T, Heinrich JJ, Keselman AC, Mendonça BB, Jorge AA.
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):450-6. PubMed ID: 17546245
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical symptoms and molecular pathogenesis of Noonan syndrome--current concepts].
    Klapecki J, Obersztyn E, Laniewski-Wollk M, Szpecht-Potocka A, Mazurczak T.
    Med Wieku Rozwoj; 2006 Apr; 10(1 Pt 2):289-308. PubMed ID: 17028394
    [Abstract] [Full Text] [Related]

  • 13. Genotype-phenotype correlations in Noonan syndrome.
    Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W, Tietze HU, Doerr HG, Hofbeck M, Singer H, Reis A, Rauch A.
    J Pediatr; 2004 Mar; 144(3):368-74. PubMed ID: 15001945
    [Abstract] [Full Text] [Related]

  • 14. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
    Padidela R, Camacho-Hübner C, Attie KM, Savage MO.
    Horm Res; 2008 Mar; 70(3):129-36. PubMed ID: 18663312
    [Abstract] [Full Text] [Related]

  • 15. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG.
    Cancer Res; 2004 Dec 15; 64(24):8816-20. PubMed ID: 15604238
    [Abstract] [Full Text] [Related]

  • 16. PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning.
    Schollen E, Matthijs G, Gewillig M, Fryns JP, Legius E.
    Eur J Hum Genet; 2003 Jan 15; 11(1):85-8. PubMed ID: 12529711
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients.
    Ferreira LV, Souza SC, Montenegro LR, Malaquias AC, Arnhold IJ, Mendonca BB, Jorge AA.
    Clin Endocrinol (Oxf); 2008 Sep 15; 69(3):426-31. PubMed ID: 18331608
    [Abstract] [Full Text] [Related]

  • 18. Does the rare A172G mutation of PTPN11 gene convey a mild Noonan syndrome phenotype?
    Kitsiou-Tzeli S, Papadopoulou A, Kanaka-Gantenbein C, Fretzayas A, Daskalopoulos D, Kanavakis E, Nicolaidou P.
    Horm Res; 2006 Sep 15; 66(3):124-31. PubMed ID: 16804314
    [Abstract] [Full Text] [Related]

  • 19. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.
    Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD.
    Nat Genet; 2001 Dec 15; 29(4):465-8. PubMed ID: 11704759
    [Abstract] [Full Text] [Related]

  • 20. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene.
    Sznajer Y, Keren B, Baumann C, Pereira S, Alberti C, Elion J, Cavé H, Verloes A.
    Pediatrics; 2007 Jun 15; 119(6):e1325-31. PubMed ID: 17515436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.